Neural bases of reward anticipation in healthy individuals with low, mid, and high levels of schizotypy.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
19 06 2023
Historique:
received: 06 03 2023
accepted: 15 06 2023
medline: 21 6 2023
pubmed: 20 6 2023
entrez: 19 6 2023
Statut: epublish

Résumé

A growing body of research has placed the ventral striatum at the center of a network of cerebral regions involved in anticipating rewards in healthy controls. However, little is known about the functional connectivity of the ventral striatum associated with reward anticipation in healthy controls. In addition, few studies have investigated reward anticipation in healthy humans with different levels of schizotypy. Here, we investigated reward anticipation in eighty-four healthy individuals (44 females) recruited based on their schizotypy scores. Participants performed a variant of the Monetary Incentive Delay Task while undergoing event-related fMRI.Participants showed the expected decrease in response times for highly rewarded trials compared to non-rewarded trials. Whole-brain activation analyses replicated previous results, including activity in the ventral and dorsal striatum. Whole-brain psycho-physiological interaction analyses of the left and right ventral striatum revealed increased connectivity during reward anticipation with widespread regions in frontal, parietal and occipital cortex as well as the cerebellum and midbrain. Finally, we found no association between schizotypal personality severity and neural activity and cortico-striatal functional connectivity. In line with the motivational, attentional, and motor functions of rewards, our data reveal multifaceted cortico-striatal networks taking part in reward anticipation in healthy individuals. The ventral striatum is connected to regions of the salience, attentional, motor and visual networks during reward anticipation and thereby in a position to orchestrate optimal goal-directed behavior.

Identifiants

pubmed: 37337085
doi: 10.1038/s41598-023-37103-2
pii: 10.1038/s41598-023-37103-2
pmc: PMC10279672
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

9953

Informations de copyright

© 2023. The Author(s).

Références

Neuroimage. 2015 Nov 15;122:427-39
pubmed: 26254587
Transl Psychiatry. 2022 Oct 16;12(1):448
pubmed: 36244990
Proc Natl Acad Sci U S A. 2020 Jun 30;117(26):15200-15208
pubmed: 32527855
Neuroimage. 2019 May 1;191:258-268
pubmed: 30710678
Neuron. 2018 Jan 17;97(2):434-449.e4
pubmed: 29307710
Schizophr Bull. 1991;17(4):555-64
pubmed: 1805349
Prog Neurobiol. 1980;14(2-3):69-97
pubmed: 6999537
Schizophr Bull. 2016 May;42(3):571-8
pubmed: 26564898
Neurosci Biobehav Rev. 2011 Apr;35(5):1219-36
pubmed: 21185861
Drug Alcohol Depend. 2013 Feb 1;128(1-2):130-9
pubmed: 22958950
Neuroimage. 2018 Sep;178:11-22
pubmed: 29733957
Front Hum Neurosci. 2015 Jun 04;9:309
pubmed: 26089783
Psychon Bull Rev. 2018 Apr;25(2):514-538
pubmed: 28986770
Proc Natl Acad Sci U S A. 2021 Oct 26;118(43):
pubmed: 34686596
Schizophr Res. 2020 Apr;218:2-6
pubmed: 31948895
PLoS One. 2018 Jun 18;13(6):e0198215
pubmed: 29912880
Neuropsychol Rev. 2018 Dec;28(4):496-506
pubmed: 30255220
Neuroimage. 2013 Feb 1;66:508-21
pubmed: 23069809
Trends Neurosci. 2007 May;30(5):203-10
pubmed: 17400301
Schizophr Bull. 2018 Jan 13;44(1):147-157
pubmed: 27798223
Hum Brain Mapp. 2018 Aug;39(8):3398-3418
pubmed: 29696725
Neuroimage Clin. 2023;37:103335
pubmed: 36736199
Neurosci Biobehav Rev. 2019 May;100:108-128
pubmed: 30807783
Hum Brain Mapp. 2018 Jan;39(1):288-299
pubmed: 29024192
Hum Brain Mapp. 2014 Jul;35(7):3036-51
pubmed: 24307490
NPJ Schizophr. 2016 Jun 15;2:16020
pubmed: 27430009
Neuroimage. 2000 Jul;12(1):20-7
pubmed: 10875899
Neuroimage Clin. 2022;33:102944
pubmed: 35078045
PLoS One. 2013 Jul 04;8(7):e68910
pubmed: 23861951
Neuroimage. 1997 Oct;6(3):218-29
pubmed: 9344826
Spat Vis. 1997;10(4):437-42
pubmed: 9176953
Nat Rev Neurosci. 2017 Feb;18(2):73-85
pubmed: 28053327
Psychiatry Res Neuroimaging. 2016 Aug 30;254:127-36
pubmed: 27419380
Neuroscientist. 2014 Apr;20(2):150-9
pubmed: 23835449
J Neurosci. 2013 Jan 16;33(3):863-9
pubmed: 23325225
Neuroimage. 2020 Feb 1;206:116189
pubmed: 31521825
Hum Brain Mapp. 2019 Jan;40(1):262-283
pubmed: 30240509
Schizophr Res. 2010 May;118(1-3):154-61
pubmed: 20005675
Spat Vis. 1997;10(4):433-6
pubmed: 9176952
Brain Struct Funct. 2010 Jun;214(5-6):645-53
pubmed: 20512378
Int J Neuropsychopharmacol. 2018 Jul 1;21(7):623-630
pubmed: 29444252
JAMA Psychiatry. 2015 Dec;72(12):1243-51
pubmed: 26558708
Schizophr Bull. 2015 Nov;41(6):1370-8
pubmed: 26006262
Biol Psychiatry Cogn Neurosci Neuroimaging. 2019 Apr;4(4):399-408
pubmed: 30691966
Nat Methods. 2011 Jun 26;8(8):665-70
pubmed: 21706013
J Neurosci. 2007 Aug 1;27(31):8161-5
pubmed: 17670959
Schizophr Res. 2020 Jun;220:69-77
pubmed: 32307263

Auteurs

F Carruzzo (F)

Clinical and Experimental Psychopathology Laboratory, University Hospital Geneva, Belle-Idée, Bâtiment Les Voirons, Chemin Petit-Bel-Air 2, 1226, Thônex, Switzerland. carruzzo.fabien@gmail.com.

A O Giarratana (AO)

Laboratory for Social and Neural Systems Research, Department of Economics, University of Zurich, Zurich, Switzerland.

L Del Puppo (L)

Laboratory for Social and Neural Systems Research, Department of Economics, University of Zurich, Zurich, Switzerland.

S Kaiser (S)

Clinical and Experimental Psychopathology Laboratory, University Hospital Geneva, Belle-Idée, Bâtiment Les Voirons, Chemin Petit-Bel-Air 2, 1226, Thônex, Switzerland.

P N Tobler (PN)

Laboratory for Social and Neural Systems Research, Department of Economics, University of Zurich, Zurich, Switzerland.

M Kaliuzhna (M)

Clinical and Experimental Psychopathology Laboratory, University Hospital Geneva, Belle-Idée, Bâtiment Les Voirons, Chemin Petit-Bel-Air 2, 1226, Thônex, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH